New observational study registered on NT-proBNP monitoring in acute heart failure
A single trial record was posted this week examining whether serial NT-proBNP measurements track with decongestion in acute decompensated heart failure patients.
This week's activity centers on one newly registered observational study.
- A prospective observational study sponsored by Mao Chen, titled "Impact of Serial Point-of-Care NT-proBNP Monitoring on Decongestion in Acute Decompensated Heart Failure," was listed as not yet recruiting, with an estimated enrollment of 50 participants1. The study aims to determine whether dynamic changes in NT-proBNP levels are associated with achievement of clinical decongestion during hospitalization under current standard treatment1, with serial NT-proBNP measurements performed during hospitalization to assess dynamic changes in NT-proBNP levels in patients with acute decompensated heart failure receiving standard guideline-directed medical treatment1. The estimated start date is 2026-08-15, with primary completion estimated for 2026-11-30.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.